학술논문
Is there evidence for different effects among EGFR-TKIs? Systematic review and meta-analysis of EGFR tyrosine kinase inhibitors (TKIs) versus chemotherapy as first-line treatment for patients harboring EGFR mutations
Document Type
Review Article
Author
Source
In Critical Reviews in Oncology / Hematology May 2015 94(2):213-227
Subject
Language
ISSN
1040-8428